A novel protocol for the one-pot borylation/Suzuki reaction provides easy access to hinge-binding groups for kinase inhibitors

por Hooper, A., Zambon, A., Springer, C. J.
Publicado 2016

Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

por Casula, M., Gazzotti, M., Bonaiti, F., OImastroni, E., Arca, M., Averna, M., Zambon, A., Catapano, A.L.
Publicado 2020

s-Heptazine oligomers: promising structural models for graphitic carbon nitride

por Zambon, A., Mouesca, J.-M., Gheorghiu, C., Bayle, P. A., Pécaut, J., Claeys-Bruno, M., Gambarelli, S., Dubois, L.
Publicado 2016

Haemato-oncology and burnout: an Italian survey

por Bressi, C, Manenti, S, Porcellana, M, Cevales, D, Farina, L, Felicioni, I, Meloni, G, Milone, G, Miccolis, I R, Pavanetto, M, Pescador, L, Poddigue, M, Scotti, L, Zambon, A, Corrao, G, Lambertenghi-Deliliers, G, Invernizzi, G
Publicado 2008

Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study

por Herrera, L., Leal, I., Lapi, F., Schuemie, M., Arcoraci, V., Cipriani, F., Sessa, E., Vaccheri, A., Piccinni, C., Staniscia, T., Vestri, A., Di Bari, M., Corrao, G., Zambon, A., Gregori, D., Carle, F., Sturkenboom, M., Mazzaglia, G., Trifiro, G.
Publicado 2015

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers

por Saturno, G., Lopes, F., Niculescu-Duvaz, I., Niculescu-Duvaz, D., Zambon, A., Davies, L., Johnson, L., Preece, N., Lee, R., Viros, A., Holovanchuk, D., Pedersen, M., McLeary, R., Lorigan, P., Dhomen, N., Fisher, C., Banerji, U., Dean, E., Krebs, M.G., Gore, M., Larkin, J., Marais, R., Springer, C.
Publicado 2021